·07/05/13 Magnetic Resonance Assessment of the Substrate for Inducible Ventricular Tachycardia in Nonischemic Cardiomyopathy
·07/05/13 Prevention of Fatal Arrhythmias in High-Risk Subjects by Fish Oil n-3 Fatty Acid Intake
·07/05/13 Coronary Stent Restenosis in Patients Treated With Cilostazol
·07/05/13 Robustness of Late Lumen Loss in Discriminating Drug-Eluting Stents Across Variable Observational and Randomized Trials
·07/05/13 Id1 Gene Transfer Confers Angiogenic Property on Fully Differentiated Endothelial Cells and Contributes to Therapeutic Angiogenesis
·07/05/13 Cardiac Troponin Elevation, Cardiovascular Morbidity, and Outcome After Subarachnoid Hemorrhage
·07/05/13 Functional Recovery of Damaged Skeletal Muscle Through Synchronized Vasculogenesis, Myogenesis, and Neurogenesis by Muscle-Derived Stem Cells
·07/05/13 Involvement of Thromboxane Receptor in the Proatherogenic Effect of Isoprostane F2-III
·07/05/13 Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E–Deficient Mice
·07/05/13 Humanitarian Use Devices/Humanitarian Device Exemptions in Cardiovascular Medicine
·07/05/13 Reverse Remodeling of the Left Cardiac Chambers After Catheter Ablation After 1 Year in a Series of Patients With Isolated Atrial Fibrillation
·07/05/13 Right Ventricular Fibrosis and Conduction Delay in a Patient With Clinical Signs of Brugada Syndrome
·07/05/13 First Evidence for Long-Term Ventricular Rate Control in Canine Atrial Fibrillation Model
·07/05/13 Transcriptomic and Proteomic Patterns of Systemic Inflammation in On-Pump and Off-Pump Coronary Artery Bypass Grafting
·07/05/13 A Noninvasive Method for Assessing Impaired Diastolic Suction in Patients With Dilated Cardiomyopathy
·07/05/13 Temporally Controlled Onset of Dilated Cardiomyopathy Through Disruption of the SRF Gene in Adult Heart
·07/05/13 Mineralocorticoid Receptor Antagonism Ameliorates Left Ventricular Diastolic Dysfunction and Myocardial Fibrosis in Mildly Symptomatic Patients With Idiopathic Dilated Cardiomyopathy
·07/05/13 Results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial
·07/05/13 Extracardiac Progenitor Cells Repopulate Most Major Cell Types in the Transplanted Human Heart
·07/05/13 Decreased Perivascular Fibrosis but Not Cardiac Hypertrophy in ROCK1+/– Haploinsufficient Mice
·07/05/13 Predictive Value of Fetal Pulmonary Venous Flow Patterns in Identifying the Need for Atrial Septoplasty in the Newborn With Hypoplastic Left Ventricle
·07/05/13 TLR2 and MyD88 Contribute to Lactobacillus casei Extract–Induced Focal Coronary Arteritis in a Mouse Model of Kawasaki Disease
·07/05/13 A Distinctive Radiographic Finding in Eisenmenger Syndrome
·07/05/13 Sildenafil in the Treatment of Raynaud’s Phenomenon Resistant to Vasodilatory Therapy
·07/05/13 Ghrelin Improves Endothelial Function in Patients With Metabolic Syndrome
·07/05/13 Leukocyte Engagement of Platelet Glycoprotein Ib via the Integrin Mac-1 Is Critical for the Biological Response to Vascular Injury
·07/05/13 The Thromboxane A2 Receptor Antagonist S18886 Prevents Enhanced Atherogenesis Caused by Diabetes Mellitus
·07/05/13 Electrophysiological Findings During Ablation of Persistent Atrial Fibrillation With Electroanatomic Mapping and Double Lasso Catheter Technique
·07/05/13 Optimal Timing of Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes
·07/05/13 Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
·07/05/13 Ambient Air Pollution Is Associated With Increased Risk of Hospital Cardiac Readmissions of Myocardial Infarction Survivors in Five European Cities
·07/05/13 Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke
·07/05/13 Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
·07/05/13 Relationship Between Procedure Indications and Outcomes of Percutaneous Coronary Interventions by American College of Cardiology/American Heart Association Task Force Guidelines
·07/05/13 Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease

1 [2] [下一页] [尾页]